Related Experiment Video
Updated: Aug 18, 2026

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
How to use the C-reactive protein in cardiac disease?
S Ursella1, M Mazzone, G Portale
1Department of Emergency Medicine, Sacro Cuore Catholic University, A. Gemelli Hospital, Rome, Italy. steura@hotmail.com
Insights
C-reactive protein (CRP) is a key inflammation marker and predictor of cardiovascular events. Elevated CRP levels indicate higher risk, guiding aggressive treatment strategies for better patient outcomes.
Area of Science:
- Cardiovascular Medicine
- Inflammation Biology
- Biomarker Research
Background:
- Inflammation plays a crucial role in atherothrombosis development.
- C-reactive protein (CRP) is a significant biomarker and active participant in atherogenesis.
- Elevated CRP levels predict adverse cardiovascular events, including myocardial infarction and death.
Purpose of the Study:
- To evaluate the predictive value of CRP in cardiovascular disease.
- To explore the utility of CRP in primary and secondary prevention strategies.
- To assess the role of CRP in guiding acute coronary syndrome management.
Main Methods:
- Analysis of prospective observational studies on CRP levels and cardiovascular prognosis.
- Evaluation of CRP's predictive value independent of and additive to troponins.
- Assessment of CRP's utility in conjunction with LDL cholesterol lowering and percutaneous coronary intervention (PCI).
Main Results:
- CRP consistently predicts new coronary events in patients with ischemic heart disease.
- Moderately elevated CRP levels are associated with adverse cardiovascular prognosis in healthy individuals.
- High CRP levels suggest a need for more aggressive medical and interventional therapies.
Conclusions:
- High-sensitivity CRP assays are valuable tools for identifying patients at cardiovascular risk.
- CRP can guide aggressive treatment strategies in acute coronary syndromes and primary prevention.
- CRP serves as a marker for investigating the inflammatory hypothesis in atherosclerosis.
Abstract:
Inflammation is an important contributor to atherothrombosis. The C-reactive protein (CRP) is not only an excellent biomarker of inflammation, but it is also a direct participant in atherogenesis. CRP consistently predicts new coronary events, including myocardial infarction and death, in patients with ischemic heart disease. The predictive value of CRP is, in the majority of the studies, independent of and additive to that of the troponins and its levels can be modulated by statins. Prospective observational studies show that moderately elevated levels of CRP are associated with an adverse cardiovascular prognosis among healthy individuals. The availability of high sensibility assays for CRP should provide a valuable tool for identifying patients at risk of cardiovascular events in primary prevention in conjunction with lowering LDL cholesterol and may also have utility in the treatment of acute coronary syndromes with percutaneous coronary intervention (PCI) therapy. High CRP levels, associated with a higher risk, should suggest a more aggressive medical therapy in the long term and also an aggressive and invasive therapy in the short term, including the use of GP IIb/IIIa inhibitors, high doses of statins, and when a PCI is necessary, provisional stenting. Finally, CRP will provide a readily accessible marker for further testing of the inflammatory hypothesis in atherosclerosis.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Acute Coronary Syndrome III: Diagnostic Studies
Rheumatic Heart Disease IV: Nursing Management